Dupont Capital Management Corp Apellis Pharmaceuticals, Inc. Transaction History

Dupont Capital Management Corp

  • $1.06 Billion
  • Q4 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Jan 26, 2023
BUY
$43.24 - $61.04 $381,938 - $539,166
8,833 Added 139.23%
15,177 $0
Q3 2022

Oct 31, 2022
BUY
$44.76 - $69.66 $142,202 - $221,309
3,177 Added 100.32%
6,344 $433,000
Q1 2022

Apr 27, 2022
BUY
$35.46 - $54.12 $112,301 - $171,398
3,167 New
3,167 $161,000

Others Institutions Holding APLS

# of Institutions
300
Shares Held
111M
Call Options Held
2.63M
Put Options Held
845K
View Full List

About Apellis Pharmaceuticals, Inc.

APLS Quotes by TradingView
  • Ticker APLS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 109,865,000
  • Market Cap $2.67B
  • Description
  • Apellis Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of therapeutic compounds through the inhibition of the complement system for autoimmune and inflammatory diseases. The company's lead product candidate is pegcetacoplan that is in Phase III clinical trials for...
More about APLS
Track This Portfolio

Track Dupont Capital Management Corp Portfolio

Follow Dupont Capital Management Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Dupont Capital Management Corp, based on Form 13F filings with the SEC.

News

Stay updated on Dupont Capital Management Corp with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email